Compare NTST & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | SDGR |
|---|---|---|
| Founded | 2019 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2020 |
| Metric | NTST | SDGR |
|---|---|---|
| Price | $17.58 | $18.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $20.27 | ★ $26.57 |
| AVG Volume (30 Days) | ★ 1.0M | 813.3K |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | ★ 4.88% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | $186,604,000.00 | ★ $256,951,000.00 |
| Revenue This Year | $17.52 | $23.69 |
| Revenue Next Year | $10.04 | $20.46 |
| P/E Ratio | $8,007.70 | ★ N/A |
| Revenue Growth | 19.54 | ★ 32.90 |
| 52 Week Low | $13.42 | $15.99 |
| 52 Week High | $19.64 | $28.47 |
| Indicator | NTST | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 39.74 | 50.16 |
| Support Level | $17.25 | $17.53 |
| Resistance Level | $18.08 | $18.28 |
| Average True Range (ATR) | 0.26 | 0.66 |
| MACD | -0.01 | 0.20 |
| Stochastic Oscillator | 31.36 | 66.25 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.